decreased transitional stage T1 B cell number_Mtor<tm1Lgm>/Mtor<tm1Lgm>

http://metadb.riken.jp/0009923I129S1SvC57BL6Mtortm1LgmMtortm1LgmMtortm1Lgm

decreased transitional stage T1 B cell number_Mtor<tm1Lgm>/Mtor<tm1Lgm>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• mechanistic target of rapamycin (serine/threonine kinase)
  http://metadb.riken.jp/db/mgi_rdf/MGI:1928394

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Mtor<tm1Lgm>/Mtor<tm1Lgm>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Mtor<tm1Lgm>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S1/Sv * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased transitional stage T1 B cell number
  http://purl.obolibrary.org/obo/MP_0009923

文献

http://purl.org/net/cito/citesAsAuthority

• Shuling. Zhang, et.al., Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production., Blood, 2011, 117
  http://rdf.ncbi.nlm.nih.gov/pubmed/21079150